917357-86-9 Usage
Uses
Used in Pharmaceutical Research and Development:
2-[Methyl-(3R)-3-pyrrolidinylamino]-ethanol is used as a chiral auxiliary in organic synthesis for its ability to influence the stereochemistry of reactions, leading to the production of enantiomerically pure compounds. This is crucial in the development of pharmaceuticals, where the stereochemistry of a molecule can significantly affect its biological activity and therapeutic efficacy.
Used in Organic Synthesis:
In the field of organic synthesis, 2-[Methyl-(3R)-3-pyrrolidinylamino]-ethanol serves as a valuable chiral auxiliary, facilitating the synthesis of complex molecules with specific stereochemistry. Its presence can guide the formation of desired enantiomers, enhancing the selectivity and yield of asymmetric reactions.
Further exploration and research are required to fully elucidate the properties and potential applications of 2-[Methyl-(3R)-3-pyrrolidinylamino]-ethanol, particularly in the context of its biological activity and its role in the synthesis of pharmaceutically relevant compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 917357-86-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,3,5 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 917357-86:
(8*9)+(7*1)+(6*7)+(5*3)+(4*5)+(3*7)+(2*8)+(1*6)=199
199 % 10 = 9
So 917357-86-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H16N2O/c1-9(4-5-10)7-2-3-8-6-7/h7-8,10H,2-6H2,1H3/t7-/m1/s1
917357-86-9Relevant articles and documents
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
-
Page/Page column 141; 142; 143, (2018/10/25)
The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1
-
, (2010/11/25)
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salts or solvates thereof, wherein n, X, Y, R1, R2, R3 and R4 are as described in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating conditions that are mediated by the modulation of 11 βHSD1 , the method comprising administering to a mammal an effective amount of a compound of formula (I).
